Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Anyone

SUMMARY:

Notice is hereby given that the U.S. International Trade Commission has

determined to review in the entirety the final initial determination (“ID”) issued by the presiding

administrative law judge (“ALJ”) on August 2, 2013, finding a violation of section 337 of the

Tariff Act of 1930, 19 U.S.C. § 1337, in this investigation.

Share
New Message
Please login to post a reply